Buprenorphine And Naloxone Tablet
NDC 67877-606
Product Information
Buprenorphine And Naloxone is a ANDA-approved product labeled by Ascend Laboratories, Llc. This medication is typically used as a opioid antagonist [epc]. It is supplied as a white tablet for sublingual administration. This product entry covers the primary NDC 67877-606 and 3 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
10 MM
BN;2
BN;8
Code Structure Chart
Product Details
What is NDC 67877-606?
What are the uses of this product?
What are Active Ingredients of this product?
- BUPRENORPHINE HYDROCHLORIDE 8 mg/1 - A derivative of the opioid alkaloid THEBAINE that is a more potent and longer lasting analgesic than MORPHINE. It appears to act as a partial agonist at mu and kappa opioid receptors and as an antagonist at delta receptors. The lack of delta-agonist activity has been suggested to account for the observation that buprenorphine tolerance may not develop with chronic use.
- NALOXONE HYDROCHLORIDE 2 mg/1 - A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- BUPRENORPHINE HYDROCHLORIDE (UNII: 56W8MW3EN1)
- BUPRENORPHINE (UNII: 40D3SCR4GZ) (Active Moiety)
- NALOXONE HYDROCHLORIDE (UNII: F850569PQR)
- NALOXONE (UNII: 36B82AMQ7N) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- MANNITOL (UNII: 3OWL53L36A)
- CROSPOVIDONE (UNII: 2S7830E561)
- STARCH, CORN (UNII: O8232NY3SJ)
- SUCRALOSE (UNII: 96K6UQ3ZD4)
- SODIUM CITRATE (UNII: 1Q73Q2JULR)
- CITRIC ACID (UNII: 2968PHW8QP)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- SODIUM STEARYL FUMARATE (UNII: 7CV7WJK4UI)
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.
Patient Education
Buprenorphine Sublingual and Buccal (opioid dependence)
Buprenorphine and the combination of buprenorphine and naloxone are used to treat opioid dependence (addiction to opioid drugs, including heroin and narcotic painkillers). Buprenorphine is in a class of medications called opioid partial agonist-antagonists and naloxone is in a class of medications called opioid antagonists. Buprenorphine alone and the combination of buprenorphine and naloxone work to prevent withdrawal symptoms when someone stops taking opioid drugs by producing similar effects to these drugs.
[Learn More]
* Please review the full disclaimer at the bottom of this page.